| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
122,563,000 |
| Market
Cap: |
6.61(B) |
| Last
Volume: |
8,264,325 |
Avg
Vol: |
8,241,969 |
| 52
Week Range: |
$26.88 - $108.06 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cytokinetics is a biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Co.'s clinical-stage drug candidates are: Omecamtiv mecarbil, which is being evaluated for the potential treatment of heart failure; Reldesemtiv, which is being evaluated for treatment in patients with amyotrophic lateral sclerosis; Aficamten, which is an oral, small molecule cardiac myosin inhibitor being evaluated in patients with symptomatic, obstructive hypertrophic cardiomyopathy; and CK-3772271, its second cardiac myosin inhibitor.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
110,593 |
276,438 |
434,458 |
898,780 |
| Total Sell Value |
$6,689,254 |
$18,972,868 |
$24,231,754 |
$44,996,315 |
| Total People Sold |
7 |
8 |
8 |
12 |
| Total Sell Transactions |
9 |
21 |
39 |
85 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jaw Ching |
SVP Finance & CFO |
• – – |
2020-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
73,165 |
|
- |
|
| Cragg David |
SVP Human Resources |
• – – |
2020-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
139,098 |
|
- |
|
| Schlossberg Mark A |
SVP - Legal & General Counsel |
• – – |
2020-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
| Wong Robert |
VP, Chief Accounting Officer |
• – – |
2020-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
13,004 |
|
- |
|
| Cragg David |
SVP Human Resources |
• – – |
2020-02-28 |
4 |
D |
$13.94 |
$19,293 |
D/D |
(1,384) |
109,098 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2020-02-28 |
4 |
D |
$13.94 |
$57,851 |
D/D |
(4,150) |
189,444 |
|
- |
|
| Malik Fady Ibraham |
EVP Research & Development |
• – – |
2020-02-28 |
4 |
D |
$13.94 |
$28,926 |
D/D |
(2,075) |
106,621 |
|
- |
|
| Malik Fady Ibraham |
EVP Research & Development |
• – – |
2020-02-27 |
4 |
D |
$13.94 |
$77,130 |
D/D |
(5,533) |
108,696 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2020-02-27 |
4 |
D |
$13.94 |
$192,818 |
D/D |
(13,832) |
193,594 |
|
- |
|
| Jaw Ching |
SVP Finance & CFO |
• – – |
2020-02-27 |
4 |
D |
$13.94 |
$38,572 |
D/D |
(2,767) |
43,165 |
|
- |
|
| Cragg David |
SVP Human Resources |
• – – |
2020-02-27 |
4 |
D |
$13.94 |
$57,851 |
D/D |
(4,150) |
110,482 |
|
- |
|
| Blum Robert I |
President & CEO |
• • – |
2020-02-26 |
4 |
D |
$14.07 |
$234,618 |
D/D |
(16,681) |
207,426 |
|
- |
|
| Jaw Ching |
SVP Finance & CFO |
• – – |
2020-02-26 |
4 |
D |
$14.07 |
$61,872 |
D/D |
(4,399) |
45,932 |
|
- |
|
| Cragg David |
SVP Human Resources |
• – – |
2020-02-26 |
4 |
D |
$14.07 |
$62,322 |
D/D |
(4,431) |
114,632 |
|
- |
|
| Malik Fady Ibraham |
EVP Research & Development |
• – – |
2020-02-26 |
4 |
D |
$14.07 |
$100,157 |
D/D |
(7,121) |
114,229 |
|
- |
|
| Lampert Mark N |
10% Owner |
– – • |
2020-02-13 |
4 |
S |
$15.79 |
$16,923,923 |
D/D |
(1,072,030) |
424,419 |
|
-53% |
|
| Blum Robert I |
President & CEO |
• • – |
2020-01-15 |
4 |
AS |
$12.96 |
$64,159 |
D/D |
(4,950) |
224,107 |
|
73% |
|
| Blum Robert I |
President & CEO |
• • – |
2019-12-16 |
4 |
AS |
$10.22 |
$61,326 |
D/D |
(6,000) |
229,057 |
|
- |
|
| Lampert Mark N |
10% Owner |
– – • |
2019-12-11 |
4 |
B |
$9.52 |
$1,126,700 |
D/D |
118,413 |
499,312 |
2.45 |
- |
|
| Lampert Mark N |
10% Owner |
– – • |
2019-12-10 |
4 |
B |
$9.40 |
$2,102,395 |
D/D |
223,659 |
490,806 |
2.45 |
- |
|
| Lampert Mark N |
10% Owner |
– – • |
2019-12-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,636,638 |
|
- |
|
| Malik Fady Ibraham |
EVP Research & Development |
• – – |
2019-12-05 |
4 |
AS |
$9.80 |
$14,700 |
D/D |
(1,500) |
121,350 |
|
- |
|
| Henderson John T |
Director |
– • – |
2019-11-19 |
4 |
B |
$8.57 |
$51,427 |
D/D |
6,000 |
6,250 |
2.39 |
- |
|
| Blum Robert I |
President & CEO |
• • – |
2019-11-15 |
4 |
AS |
$8.08 |
$48,508 |
D/D |
(6,000) |
235,057 |
|
- |
|
| Malik Fady Ibraham |
EVP Research & Development |
• – – |
2019-11-07 |
4 |
AS |
$9.98 |
$14,970 |
D/D |
(1,500) |
122,850 |
|
- |
|
710 Records found
|
|
Page 24 of 29 |
|
|
1.22 (2.31%) 
